Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of changes, notices of special interest NOSI, and funding opportunities.
Policy Notices
- Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
National Institutes of Health
- Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
National Institutes of Health
General Notices
- Notice of Early Expiration of NOT-AI-20-051 Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases
- Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
National Institute of Allergy and Infectious Diseases
- Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice to Encourage Eligible NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees to Apply for PA-20-222 "Research Supplements to Promote Diversity in Health-Related Research"
National Institute of Neurological Disorders and Stroke
- Notice of Technical Assistance Webinar for Two NIH Multimorbidity FOAs - PAR-20-179 and PAR-20-180
Office of Disease Prevention
- Notice Regarding Revision and New Applications under PAR-15-352: Occupational Safety and Health Training Project Grants (T03)
National Institute for Occupational Safety and Health
- Notice Regarding New ERC Applications for PAR-15-303: Occupational Safety and Health Education and Research Centers (T42)
Institute for Occupational Safety and Health
- Request for Information (RFI): Inviting Comments and Suggestions on University-Based Approaches for COVID-19 Surveillance Testing to Review the Current Landscape
National Institutes of Health
Notice of Changes to Funding Opportunities
- Notice of Change to RFA-DA-21-005 "Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)"
National Institute on Drug Abuse
- NHLBI confirms participation in NOT-OD-20-119, NOT-OD-20-120, and NOT-OD-20-121 (Research on COVID-19 Testing among Underserved and/or Vulnerable Populations)
National Heart, Lung, and Blood Institute
- Notice of Correction to "PAR-20-235, Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required)"
National Institute of Mental Health
- Notice of Change to Key Dates for PAR-18-528 "NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
- Notice of Change to Key Dates for PAR-18-628 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
- Notice of Change: Late Application Policy for September 28, 2020, Application Due Date for RFA-NS-21-001 "NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
- Notice of Change: Late Application Policy for September 28, 2020, Application Due Date for RFA-NS-21-002 "NINDS Exploratory Grant Program in Parkinson's Disease Research (P20- Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
- Notice of Change to Key Dates for PAR-18-563 "NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
- Notice of Intent to Publish a Funding Opportunity Announcement for Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
Notices of Special Interest
- Notice of Special Interest: Secondary Analyses of Existing Alcohol Research Data
National Institute on Alcohol Abuse and Alcoholism
- Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Mental Health
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
- Notice of Special Interest (NOSI): Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations
National Institute on Minority Health and Health Disparities
Funding Opportunities
- NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
- Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
National Institute of Mental Health
- Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)
National Cancer Institute
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
National Institute on Aging
- Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
National Cancer Institute
- Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed) Lewy Body Dementia or Frontotemporal Dementia
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
National Institute for Occupational Safety and Health
National Institute on Aging
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu